icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
YUS8KEXTLww77hjD
Listen
